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CHAPTER 1 
Introduction 
300,000 to 500,000 annual deaths in the United States are attributed to sudden 
cardiac failure [1]. While remaining the leading cause of death in industrially developing 
countries, effective diagnosis remains an elusive target. Although there are current 
diagnostic tools that can identify patients at risk for sudden death, these techniques are 
not without limitations.  For example, heart rate variability (a marker for cardiac vagal 
tone), only analyzes the beat to beat variability in R-R interval of the electrocardiogram 
(EKG). This type of analysis neglects valuable information that may be contained in 
other portions of the EKG, particularly the T wave. The T wave may provide 
information about alterations in repolarization of the cardiac tissue that have been linked 
to arrhythmia formation.  Therefore, a comprehensive analysis of the T wave (both 
changes in peak and shape) could provide novel approach for the identifications of 
patients at risk for cardiac related deaths.  
A well established canine model of ventricular fibrillation (VF) provided a data set 
collected over the last 25 years that can be used to analyze and to identify factors that 
could be related to the risk for VF. This comprehensive and complete data set, along with 
each dog’s continuous electrocardiogram (EKG), provides many examples of animals that 
were either susceptible or resistant to VF. Using these data, a spectral analysis of the 
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dog’s EKG T wave variation can provide a new noninvasive, quick and effective method 
for determining a canine’s susceptibility to VF. 
This knowledge can then be applied in other aspects of diagnosis and treatment 
ranging from future anti-arrhythmic drug development to a less costly, more effective, 
internal defibrillator along with simpler methods of identifying patients at risk of cardiac 
disease and tailoring an appropriate therapy for each patient [1].  
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1.1 Heart electrochemical gradients 
Ventricular Fibrillation (VF) is an abnormality in cardiac electrical activity that 
results in rapid, unsynchronized contractions of the ventricles such that heart is unable to 
pump blood to the rest of the body.   This lack of blood flow leads to irreversible damage 
of the brain, heart and other tissue leading ultimately to death. To better understand VF, 
we look at the electrical properties of the heart. 
The heart can be considered a simple circuit controlled by action potentials that 
result from characteristic changes in the electrochemical gradients of different ions. The 
ventricular myocardial membrane potential of a resting heart (not contracting, not de-
polarizing or re-polarizing) during the T-P interval is -90mV. The ions responsible for 
spreading excitation through the heart muscles are potassium (K+), sodium (Na+), and 
calcium (Ca2+). At rest the permeability to potassium ions is high while the sodium and 
calcium permeabilities are low.  Changes in these permeabilities produce the cardiac action 
potential. Depolarization of the ventricle action potentials results from sodium ions 
flowing (increase in sodium permeability) into the heart resulting in a membrane potential 
of approximately 10mV.  Once a critical voltage (threshold) has been reached the sodium 
permeability decreases as the result of inactivation or closure of   Na+ channels. (Note 
“closing” means the flow is much more limited, but is not entirely stopped)  
The closing of these channels creates a plateau at approximately 0mV.  Next, the 
permeability of calcium into the myocardial cell increases as the result of opening calcium 
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channels.  The plateau is maintained by the restriction of potassium leaving the cell 
(closure of potassium channels) to match the calcium entering the cell.  The result of 
calcium flow into the cell, balances the positive potassium flow out of the cell to maintain 
a plateau membrane permeability of 0mV.  
This plateau is responsible for the refractory period of the heart, the length of 
time at which the heart cannot generate new action potentials. It is by this process the 
healthy heart avoids contracting rapidly at close intervals.  While the pacemaker effect of 
the heart is determined by the spontaneous diastolic depolarization of specialized 
“pacemaker” cells, for simplicity think of this plateau as a cardiac regulator. The plateau 
prevents the heart from immediately re-contracting, allowing the atria and the ventricles to 
operate separately and rhythmically. Most importantly, if this plateau did not exist the 
heart would not be able operate properly. Finally, repolarization (i.e. the return to resting 
potential) results from the closure of the calcium channels and the opening of potassium 
channels, such that fewer positive ions enter (calcium ions) the cell than leave (potassium 
ions) thereby returning the membrane potential to -90mV. The membrane potential 
recording from a ventricular muscle cell and the permeabilities of potassium, sodium, and 
calcium during action potentials can bee seen in Figure 1 and Figure 2 respectively [2]  
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The action potentials created by these electrochemical gradients help generate a 
baseline pacemaker effect for the heart. The pacemaker potential is the spontaneous 
depolarization during diastole of specialized cells usually located in the right atrium at or 
near the sino-atrial node. This pacemaker depolarization, caused by electrochemical 
gradients, can be modified by sympathetic neural activity (increased discharge rate) or 
parasympathetic activity (decreased discharge rate). Ventricular action potentials can be 
influenced by factors that alter the ion permeability and/or the electrochemical gradient.  
These factors include myocardial ischemia and alterations in the autonomic neural 
regulation of the heart.  Abnormalities in these ions can lead to cardiac rhythm disorders 
including ventricular fibrillation 
 
Figure 1: Membrane 
potential recording from a 
ventricular muscle cell 
Figure 2: Simultaneously measured 
permeabilities (P) to potassium, 
sodium, and calcium during the 
action potential of figure 1 
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1.2 Heart analyzers 
Analyzing an EKG enables a cardiologist to identify cardiac arrhythmias ranging from 
cardiac arrest, ventricular tachycardia, ventricular fibrillation, to simple pre-ventricular 
contractions (PVCs).  The EKG can also provide information as to factors that have been 
linked to a greater risk for rhythm disorders. Heart rate variability (HRV) as an index of 
cardiac vagal tone is often used to predict which patients have the greatest risk for cardiac 
arrhythmias.  
 Heart rate variability provides an indirect measure of cardiac parasympathetic 
response to the activity of the vagus nerve (i.e. cardiac vagal tone).  The best way to 
understand this concept is through example.  This heart rate variability is associated with 
changes in respiration and is often called a respiratory sinus arrhythmia.  During 
inspiration, cardiac vagal activity is inhibited resulting in increase in heart rate while 
during expiration cardiac vagal activity increases, decreasing heart rate. This beat to beat 
variation in heart rate demonstrates that the heart can respond rapidly to changing 
environmental demands and is taken as sign of good cardiac health. 
HRV has been significantly correlated with the autonomic nervous system and 
cardiovascular mortality. HRV describes variation of instantaneous heart rate for R-R 
intervals in an EKG. Figure 3 shows a varying R-R interval. [3] 
 
 
 14 
Figure 3: EKG demonstrating Heart Rate Variability 
HRV is related to changes in the sinus (atrial pacemaker) rhythm but ventricular 
arrhythmias are excluded from HRV analysis proving unhelpful when analyzing 
ventricular fibrillation. As such, HRV does not provide a complete measure of how the 
heart response to arrhythmias.  HRV is, however, used to provide a marker of the general 
electrical stability of the heart.  A high HRV indicates that the heart can respond to 
changing demands thereby having a better electrical stability than patients with low HRV. 
This high heart rate variability correlates to a high vagal tone and a high vagal tone 
increases the electrical stability of the heart making it less likely that stress will provoke 
VF. 
 T wave analysis can compensate for shortcomings of HRV analysis by providing 
information about repolarization of the heart.  Heterogeneity of repolarization (regional 
differences in repolarization) increases the risk for the formation of arrhythmias, which 
are pre-cursors to VF.  T wave analysis could provide information about these 
repolarization abnormalities. The current method used to determine a heart’s probability 
of going into VF is to analyze the alternating peaks of the T waves.  T wave peak 
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alternans are analyzed for variations and sinusoidal rhythms. It is hypothesized if 
variations exist then a canine will be susceptible to ventricular fibrillation. [4] 
Studies have shown that canines (and hypothesized in humans) are genetically 
predisposed as resistant or susceptible to VF. A susceptible canine will go into induced 
ventricular fibrillation and a resistant canine will not.  While there are many different 
cardiac diagnostic tools to obtain data to analyze the heart, few exist to diagnose 
arrhythmias, which may lead to VF. Only one currently exists to predict VF.  
1.3 Cardiac testing tools  
Currently there are many testing methods used to collect cardiac data. To name a 
few, methods used to collect data are stress testing, radioactive tracer tests, and 
echocardiography.  From these data, tools can determine HRV, an index of cardiac vagal 
tone, coronary blood flow, and ischemia. While these symptoms may interrelate 
providing valuable data regarding the heart arrhythmias and the possibility of VF, they 
cannot measure changes in ventricular repolarization that have been linked to an increased 
risk of VF. The only test that does measure VF directly is the electrophysiological test. 
To analyze the heart response to factors leading to VF, the current diagnostic 
tools can determine HRV, an index of cardiac vagal tone, but cannot measure changes in 
ventricular repolarization that have been linked to an increased risk for VF. Additionally, 
the current methods for measuring the risk of VF are not always reliable, are not without 
risk, and neglect important components of EKG that are explored in this thesis. 
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 Current methods for collecting cardiac data during situations that can be pre-
cursers to cardiac trauma are the stress test, echocardiography, radioactive tracers, and 
electrophysiological testing. The electrophysiology test is an invasive test that stimulates 
the heart by electrical impulses. The invasive surgery is simply the insertion of a catheter 
into the groin.  The catheter is threaded to the heart, where it evaluates the hearts 
conductive properties. The catheter also delivers electrical impulses to the heart causing 
increased heart rate and minor arrhythmias.  The test is designed to see how the heart 
responds to rhythm disturbance, a.k.a arrhythmias. The test is dangerous for two reasons. 
Firstly, any invasive procedure comes with risk, but an invasive procedure that forces 
arrhythmias to the heart is even riskier. The test is also expensive because of the 
personnel, equipment, and time needed during the procedure. 
 The radioactive tracer test details blood flow to the sections of the heart providing 
valuable information about infarct tissue, but does not provide information regarding the 
electrical impulses and action potentials that lead to VF. The tracer characterizes 
ischemia, which affects the electrical system in the heart, but does not directly assess 
arrhythmias.  In addition to not classifying arrhythmias, the use of radioactive isotopes 
may have adverse health effects too. 
 The echocardiography test is essentially an ultrasound. This test provides 
information regarding the mechanical function of the heart and coronary blood flow. It is 
not used to diagnosis arrhythmia risk, but a well established association with left 
ventricular function and mortality has been tied to these test results. Patients with low 
 17 
ejection fractions and stroke volume can be warned of these potential issues by the non-
invasive procedure. Additionally, the diagnosis based on an echocardiography is 
dependent upon the physicians experience, knowledge, and keen eye of all which have a 
wide statistical variation.  
The stress test, while being a good test for determining HRV and vagal tone, do 
not provide detailed information in assessing arrhythmia risk. The data collected from the 
stress test is used to test underlying coronary blood flow problems. Problems that may 
lead to ischemia in turn affecting the electrical system in the heart. Even though the test 
may provide some information, it has high false negatives, especially when diagnosing 
females.  
1.4 Problem statement 
Knowing ischemia induces higher heart rate and the potential for interrupting the 
electrochemical gradient needed to maintain the refractory period of the heart, ischemia 
produces prime conditions for VF. Knowing the T wave of an EKG measures the 
repolarization characteristic of the ventricle, searching for abnormalities and T wave 
variations between resistant canines and susceptible canines may provide detail 
information allowing for the pre-diagnoses of arrhythmias that lead to VF.  Additionally, 
knowing the current T wave analysis methods, ones only focusing on the peaks of each 
wave, neglects important information and has not proved accurate or viable in analyzing 
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the risk of VF, it seems best to combine the concepts ischemia and full T wave analysis to 
determine a subjects risk to VF.  
 To combine the two concepts, analyzing the T wave of an EKG signal during four 
stages, control, occlusion, reactive hyperemia (recovery), and fully recovered can allow 
for the analysis between susceptible canines and resistant canines to determine if there are 
any variations useful in predicting the canine susceptibility or resistance to VF. It is 
hypothesized while the heart is experiencing ischemia, demonstrated in the occlusion 
stage, that variations will become more apparent between susceptible and resistant 
canines. This is what is to be determined this thesis. 
1.5 Organization 
In the following chapter, we discuss the methodologies used during the data collection 
procedures. The experiments used to analyze the data collected will be outlined too.   
 Chapter III presents the results of the experiments by searching for statistical 
significance in the experimentally processed data. 
Finally, this thesis concludes with a summary and implications of the results, Chapter IV. 
Also, suggestions for possible research in the area are made.  
 19 
CHAPTER II 
METHODOLOGY 
This section explores the methods used to collect data for analysis, the isolation of the 
necessary data, and the experiments used to analyze the isolated data. 
2.1 Animal preparation and protocol for separation of groups 
In order to perform a spectral T wave analysis as specified by the problem statement in 
Chapter I, an accurate set of data must be collected. The data are critically dependent 
upon the model used.  The model must mimic, as closely as possible, the underlying 
pathological conditions associated with a high risk of sudden death. Studies indicate that 
among the most important factors associated with a high risk of sudden death, previous 
myocardial ischemic injury and infracted myocardium tissue are most important. The data 
pools analyzed are composed of canines prepared by surgery to mimic these ischemic 
pathological conditions. 
 To prepare the canine’s pathological conditions, open-heart surgery is performed. 
During surgery, preventing blood flow to the anterior portion of the heart induces an 
anterior myocardial infarction. An occluder/flow monitoring device, here after referred to 
as the occluder, is then placed around the left circumflex artery. This occluder is later used 
manually to induce acute ischemia and monitor coronary blood flow. Inducing ischemia 
coupled with the previous infarct tissue generates the necessary components to cause VF. 
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Monitoring the blood flow through the artery is performed by a pulsed Doppler coronary 
flow transducer.  The Doppler technique sends an ultrasonic pulse into the blood stream 
that is reflected off the red blood cells. The signal is shifted proportional to the blood 
flow velocity (i.e., the Doppler shift). EKG leads are also placed on the heart. Two sets 
of electrodes are sutured to the left and right ventricle to record the canine’s EKG during 
testing. 
 Once the canines are fully recovered from surgery and trained to run on a 
motorized treadmill, EKG and CBF data are collected under two types of cardiac stress: 
rest and exercise. During rest EKG data and CBF data was taken for a total of 10 minutes. 
The first 3 minutes were to get a control EKG sample. The next 2 minutes where taken 
while the circumflex artery was occluded by the occluder and ischemia was induced. The 
next 5 minutes was post occlusion and can be broken down into the recovery stage and 
the recovered stage. The recovery stage immediately follows the occlusion release and the 
recovered stage is about 2 minutes after the occlusion release.  
VF susceptibility vs. resistance for each canine is then determined by performing 
an exercise plus ischemia test.  Animals will run 15-18 minutes with work load increasing 
every 3 min until a heart rate of 210 beasts/min is achieved. During the last minute of 
exercise the left circumflex occluder is inflated, the treadmill is stopped and the occlusion 
maintained for an additional minute. The total occlusion length is 2 minutes: 1 minute 
during exercise and 1 minute post exercise. This allows for the differentiation of 
arrhythmias induced during exercise, post exercise, and post occlusion release. The 
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occlusion is immediately released in those animals that exhibit ventricular 
tachyarrhythmia that most frequently becomes ventricular flutter that rapidly deteriorates 
into VF determining a canine’s susceptibility to VF. 
The recording of the coronary blood flow (CBF) is an important step. While data 
are being collected the occluder is inflated to induce ischemia. Ischemia, as mentioned 
before, is important because it creates an environment primed for VF by effecting HRV 
and electrochemical gradients. Not only does it increase heart rate but it also blocks blood 
flow to the myocardium. If the myocardium does not receive blood then the channels 
controlling the electrochemical gradient are unable to function therefore preventing proper 
action potentials leading to ventricular tachycardia and/or VF. For these reasons the EKG 
signal and the CBF through the left circumflex is monitored during 4 stages at rest and 
exercise: Control, Occlusion, Recovery, and Recovered. These fours sections will be 
explained in more detail later. For this thesis, the EKG signals and CBF signals of 
resistant and susceptible canines were examined from the 10 minute rest period. 
2.2 T wave isolation 
In order to perform a spectral T wave analysis as specified by the problem statement in 
Chapter I, EKG and CBF data are collected from 14 pre-identified susceptible or resistant 
canines. (susceptible, n=8; resistant, n=6). Each subject’s EKG was then subdivided into 
four epochs: the control epoch, occlusion epoch, recovery epoch, and the recovered 
epoch.  
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The control epoch of the data is used as a control signal for each canine subject. 
This is the 3 minute rest period before occlusion. The occlusion section of the CBF 
represents ischemia, one epoch of interest.  During the occlusion section, the occluder is 
manually inflated to block blood flow through the circumflex coronary artery causing an 
ischemic response in the heart. The recovery section occurs when the occluder is released 
allowing blood to flow back to the heart. Finally, the recovered section represents the 
CBF stabilizing and providing a steady flow of blood. 
2.2.1 Epoch definition from data 
In order to properly analyze the T wave of the EKG during each epoch condition 
the corresponding epoch section of data must be accurately located. Locating these points 
was done by analyzing the CBF. The control epoch and the recovered epoch were easily 
isolated since they are the first 60000 and last 60000 data points of the EKG and the 
CBF data. To locate the start and stop point of the occlusion, windowing threshold 
detection was used. As shown in Figure 4, the starting position of the occlusion was 
found when the maximum value of the data points in the windowed data was less than 
0.5V and the stop point was when the maximum value in the windowed data was greater 
than 0.5V. The value 0.5V empirically determined and varied subject to subject. The 
window size was determined as the maximum distance between two consecutive QRS 
signals in the EKG data, and the threshold of 0.5volts was chosen by visually inspecting 
the CBF to see what values corresponded to a drop in blood flow. Threshold varied from 
animal to animal.  Some CBF data showed the occlusion section rose instead of dropped. 
 23 
This was simply caused by reversing the connecting wires causing the CBF output signal 
to be inverted. 
 
 
 
 
Figure 4: Coronary Blood Flow (CBF) sectioned into epoch zones 
Once the occlusion start location was determined, data were taken for 60000 
points (2 minutes). This 2 minute section captured the entire occlusion section, because a 
standard protocol was used when capturing data - 3 minute control, 2 minute occlusion, 5 
minutes post occlusion. Finally, since the end occlusion data point was previously found, 
the recovery section was easy to isolate too. The final stage was to transfer the timing of 
epochs found in the CBF to the EKG signals. Since the sampling rate for the CBF was the 
same as the EKG’s, locating the epochs on the EKG was a simple transferred from the 
CBF to the EKG as shown in Figure 5. 
 
 
 
Control 
Recovery 
Occlusion Recovered 
 volts  
Data 
points 
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Figure 5: EKG sectioned into epoch zones 
2.2.2 Selection of T wave windowing 
The next step in the data collection procedure is to locate the T wave. Locating the 
T wave can be difficult, but finding the QRS complex is simple. Since the QRS is a 
dominant component of the EKG and has a much larger peak than other values it can be 
found. A match filter technique using an ideal QRS signal and convolving it with each 
EKG section was used to determine the location of each QRS segment. Then using 
threshold detection, on the filtered EKG, the index locations of the QRS were found. A 
four-part picture showing the expanded sections of the EKG to be analyzed, the ideal-
QRS, the convolution, and the QRS detection is shown in Figure 6.  
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Figure 6: QRS detection. Zoomed in portion of EKG to be analyzed (top), ideal-QRS    
(middle top), zoomed in portion of convolution of ideal-QRS and EKG (middle bottom), QRS 
detected (bottom) 
Once the QRS location is detected the T wave windows can be determined. T 
waves at times are very difficult to detect not to mention the T wave variations being 
explored by this thesis. To capture the T wave, a delay is implemented after the QRS 
complex.  The delay, typically 15 data point or 30 ms, was chosen empirically for each 
subject, so that a T wave isolation window did not include any part of the QRS complex.  
The T wave isolation window is a 64 data point (128ms) wide window. The window size 
was chosen for two reasons. Firstly it is large enough to include the entire T wave while 
ignoring unwanted parts of the EKG like the P wave. Secondly the window size was 
chosen to be a power of 2 (2p = 64, p=6) because the properties of Fourier transforms 
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calculate quicker for powers of 2. Another beautiful aspect of the FFT properties is that 
even though the T wave window consisted of 64 data points, only 32 need to be analyzed 
and viewed because the FFT is symmetric. Thus if data point 64 is the same as data point 
1, there is no need to look at them both since one will tell use the same information as 
both. 
 The use of the FFT is to convert the time domain T wave data into the frequency 
domain allowing for spectral analysis.   Data in the frequency domain allows for an easier 
analysis of smooth and abrupt changes seen in the time domain.  Converting to the 
frequency domain takes gradual slope changes in a T wave and characterizes them to low 
frequencies and sharp slope changes are characterized to high frequencies.  This allows for 
numerical interpretation of T wave changes. These frequencies can then be analyzed in 
terms of magnitude or phase.   
 The phase portion of the spectral T wave data is of no interest in this study. The 
phase is ignored because, as said before, all canines have a different pause needed to 
isolate the T wave. Additionally, to assure the data being analyzed were not corrupted by 
baseline (DC) drift, 60 Hz signal from the wall outlets or any of 60Hz harmonics, these 
values were removed from the T wave spectral data. In order to analyze the magnitude 
portion of the T wave, the absolute value (ABS) of the T wave frequency spectrum is 
taken.  
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2.2.3 Noise reduction in epoch spectra 
 The last step in preparing the spectral T wave data is to remove excess noise in 
the signal. Each epoch contains approximately 400 T waves. Removing excess noise is 
accomplished by averaging each frequency of the spectrum over all cardiac cycles in the 
epoch. Figure 7 shows the T wave spectral data before and after averaging across cardiac 
cycles. 
 
 
 
 
 
 
 
 
 
Figure (7): Spectral T wave data (top); Spectral T wave data 
averaged across cardiac cycles (bottom)1 
2.3 Experiments   
The concepts of both section 2.1 and section 2.2 were applied to a set of 14 canine EKG 
traces. 6 of the 14 traces were collected from VF resistant canines and the other 8 were 
collected from VF susceptible canines. The following experiments were applied to the 
data. 
Frequency 
Frequency 
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2.3.1 Experiment 1 
Keeping in mind that t wave spectral differences between resistant and susceptible 
canines are hypothesized as more apparent during ischemia, the root mean square (RMS) 
difference between full spectrum of occlusion, recovery, and recovered epochs vs. the 
control epoch, were studied.  The data manipulation to perform this RMS comparisons 
were as follows: To normalize the data, the averaged full spectrum T wave in each of the 
occlusion recovery, and recovered epochs were subtracted from the averaged control 
spectral epoch. This subtraction allowed each animal to have its own control T wave 
spectrum. After subtraction, the frequency samples for each animal where squared, 
averaged and then the square root taken for each epoch. The RMS was computed for the 
variations of each epoch comparison for resistant and susceptible canines, and finally a 2 
sample ttest with different variances was performed comparing resistant and susceptible 
canines using Matlab. 
The ttest2 function on Matlab assesses whether means of two groups are 
statistically different from each other. The null hypothesis is that the means are the same. 
In context to the EKG data being analyzed, the objective is to reject the null hypothesis 
indicating that there is a difference between the susceptible and resistant T wave RMS 
spectral means. The ttest2 function returns the values H, P, and Ci.  H is the acceptance 
or rejection of the null hypothesis of the probability of observing a value with the same 
mean (H  = 0 acceptance the null, H=1 rejects the null hypothesis). P is the significance of 
data, the probability, under the null hypothesis, of observing more extreme test statistics. 
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A P value less than 0.05 or 5% will reject the null hypothesis and is what this thesis 
seeks. Ci is the confidence level. 
 To analyze the RMS data of the full spectral T wave data, it is broken down into 
two tables. Table 1 shows the data for the spectral T waved data for resistant canines and 
Table 2 shows the spectral T wave data for susceptible canines. 
Table 1: RMS of spectral T wave epoch comparison data for resistant canines 
Table 2: RMS of spectral T wave epoch comparison data for susceptible canines 
These comparisons were visually analyzed for trends and variations. Figure 8, 
below, shows the averaged spectral T wave epoch for each resistant and susceptible 
canine.   
Canine ID Occlusion epoch Recovery epoch Recovered epoch
614 0.1444 0.0406 0.0338
697 0.2148 0.0671 0.0277
738 0.08 0.0242 0.0223
761 0.0203 0.0063 0.0088
674 0.2573 0.0622 0.0456
725 0.043 0.0384 0.0276
RMS Resistant T-wave Spectral analysis  
Canine ID Occlusion epoch Recovery epoch Recovered epoch
617 0.0357 0.0467 0.015
699 0.1777 0.0969 0.0516
722 0.0281 0.0499 0.0216
734 0.0315 0.0091 0.0085
764 0.2771 0.1737 0.0792
691 0.673 0.6814 0.4525
778 0.1198 0.0584 0.0837
784 0.1059 0.0669 0.0354
RMS Susceptable T-wave Spectral analysis  
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Figure 8: Averaged Spectral T-wave control epoch vs. occlusion epoch for tested 
subjects 
 
2.3.2 Experiment 2 
Experiment 2, is almost identical to Experiment 1. There is, however, an extra step. 
Before taking the RMS of the full spectral data, the T wave spectral data is segmented 
into four sections: High, Mid-High, Mid-Low, and Low frequencies with each section 
being composed of about 70Hz. Figure 9, shows the segmented averaged spectral T wave 
control epoch vs. the averaged spectral T wave occlusion epoch for each resistant and 
susceptible canine.  
 31 
Figure 9. Segmentation of T wave spectrum into 4 sections for concentrated analysis. 
The RMS of each section for each epoch comparison was computed for both resistant 
and susceptible canines, to determine variations for each epoch comparison, as shown in 
Tables 3, below.  
Table 3: RMS Spectral T wave data of segmented data 
Canine 
ID
Segment 1 
occlusion 
epoch
Segment 2 
occlusion 
epoch
Segment 3 
occlusion 
epoch
Segment 4 
occlusion 
epoch
Segment 1 
recovery 
epoch
Segment 2 
recovery 
epoch
Segment 3 
recovery 
epoch
Segment 4 
recovery 
epoch
Segment 1 
recovered 
epoch
Segment 
2recovered 
epoch
Segment 3 
recovered 
epoch
Segment 4 
recovered 
epoch
614 1.7814 0.6694 0.4964 0.3633 1.7774 0.5345 0.6842 0.2951 1.8876 0.1803 0.6276 0.1021
697 1.7596 0.7138 0.4948 0.3867 1.8155 0.5819 0.5144 0.3177 1.3268 0.9795 1.0001 0.5292
738 1.3801 1.1106 0.7016 0.6079 1.4842 0.7566 1.0296 0.4054 1.6167 0.3322 1.1148 0.1814
761 1.8149 0.6001 0.4963 0.3157 1.8612 0.0394 0.7304 0.0317 1.9323 0.1124 0.5018 0.0427
674 1.6044 0.8889 0.6356 0.4815 1.3891 0.9418 0.9581 0.5152 1.6969 0.464 0.9146 0.2622
725 1.6978 0.7651 0.5865 0.4336 1.9783 0.1359 0.2407 0.0994 1.6904 0.7391 0.6378 0.4353
Canine 
ID
Segment 1 
occlusion 
epoch
Segment 2 
occlusion 
epoch
Segment 3 
occlusion 
epoch
Segment 4 
occlusion 
epoch
Segment 1 
recovery 
epoch
Segment 2 
recovery 
epoch
Segment 3 
recovery 
epoch
Segment 4 
recovery 
epoch
Segment 1 
recovered 
epoch
Segment 
2recovered 
epoch
Segment 3 
recovered 
epoch
Segment 4 
recovered 
epoch
617 1.6184 0.8858 0.6088 0.4748 1.9946 0.0894 0.1049 0.049 1.9186 0.3669 0.3782 0.203
699 1.5911 0.919 0.612 0.4993 1.7094 0.7882 0.5296 0.4196 1.6845 0.8037 0.5733 0.4336
722 0.888 1.3086 0.9963 0.7115 1.3444 1.1275 0.7389 0.6126 1.1541 1.0536 1.1019 0.5864
734 1.8174 0.5712 0.5271 0.305 1.7266 0.0774 1.0053 0.0464 1.0245 1.1832 1.0797 0.6201
764 1.7169 0.7798 0.5199 0.4169 1.9781 0.2099 0.1747 0.1117 1.9144 0.3958 0.3576 0.2248
691 1.8938 0.5143 0.3055 0.2364 1.9046 0.4879 0.29 0.224 1.911 0.47 0.2859 0.2132
778 1.9846 0.1616 0.1732 0.0725 1.8989 0.4025 0.4589 0.1463 1.9838 0.0149 0.2537 0.0028
784 1.5676 0.9429 0.6335 0.5024 1.9544 0.3035 0.2529 0.1561 1.8694 0.5024 0.4339 0.2539
RMS of sectioned Susceptable T-wave Spectral 
RMS of sectioned Resistant T-wave Spectral 
analysis  
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Finally a 2 sample ttest with different variances was performed comparing resistant and 
susceptible canines. The results are discussed in Chapter 3. 
2.4 FAILED EXPERIMENTS 
One other, unsuccessful experiment performed on the data comparing the T wave spectral 
alternans. Traditional alternan analysis compares the T wave peaks (max value) of 
consecutive T waves and analyzes for variations like sinusoidal rhythms. It is 
hypothesized if such variations exist then a canine will be susceptible to VF. 
T wave alternans as pertaining to this thesis is comparison of even and odd T 
waves. To separate and compare the alternans T wave, data were separated into even and 
odd groups. The odd group was composed of the 1st, 3rd, 5th….T wave found in the EKG 
data, while the even group was composed of the 2nd, 4th, 6th….T wave found in the EKG 
data. These two vectors were subtracted yielding alternan spectral T wave data in 
addition to the spectral T wave data. The advantage to analyzing T wave alternans, as 
defined, is the removal of baseline drift from the spectrum signals. The results of this 
experiment were not statistically significant because no patterns were observed.   
.  
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CHAPTER III 
RESULTS ANALYSIS 
This chapter reports the results of experiment 1 and experiment 2, previously discussed 
in Chapter 2. 
3.1 ttest2 statistical analysis 
The subject pool for this thesis originated with 5 canines susceptible to VF canines and 4 
canines resistant to VF.  After processing the RMS of the spectral T wave epoch 
comparison data using the ttest2 function, described in section 2.3, the null hypothesis 
was accepted. The results of the ttest2 operation can be seen in Table 4. 
Table 4: ttest2 results of RMS resistant compared to  
RMS susceptible T wave Spectral data 
 
The null hypothesis was not rejected because of the high p-values returned by the ttest2 
function.  To reject the null hypothesis, determining variations between resistant and 
susceptible T wave spectral epochs, the p-values of each epoch section need to be less 
then 0.05 or 5%.  
8 RMS susceptible canine T-wave Spectral data
Occlusion 
Epoch
Recovery 
Epoch
Recovered 
Epoch
H: 0 0 0
P: 0.4951 0.5612 0.7353
C: -0.0021 -0.0038 -0.0033
0.004 0.0023 0.0025
ttest2 results of 6 RMS Resistant canines  compared to 
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 Since analyzing 3 susceptible and 2 resistant canines failed to reject the null 
hypothesis and returned high p-values, the subject pool was increased to 8 susceptible 
and 6 resistant canines with hopes of lowering the p-value and in turn rejecting the null 
hypothesis. The RMS for the T wave epoch comparison data, shown in Tables 1 and 2, 
was processed with the ttest2 function with Table 5 showing the results. 
Table 5: ttest2 results of 6 RMS resistant canines compared to  
8 RMS susceptible canines T wave Spectral data 
 
The new ttest2 results of the larger sample data yielded a promising outcome. 
Even thought the null hypothesis still fails to be rejected, the p-values with larger groups, 
has dropped greatly. The occlusion epoch p-value differed from 0.4951 to 0.5401, and the 
recovery epoch p-value dropped from 0.5612 to 0.2108, and the recovered epoch p-value 
dropped from 0.7353 to 0.2494. The recovery and recovered epoch data gave very 
promising results that with larger samples a rejection of the null hypothesis maybe 
possible and reinforces that looking at the recovered and recovery epochs may provide 
more valuable data than the ischemic section as originally thought. But the null 
hypothesis was still accepted. 
8 RMS susceptible canine T-wave Spectral data
Occlusion 
Epoch
Recovery 
Epoch
Recovered 
Epoch
H: 0 0 0
P: 0.5401 0.2108 0.2494
C: -0.1365 -0.0769 -0.0578
0.2453 0.293 0.1895
ttest2 results of 6 RMS Resistant canines  compared to 
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Still needing to reject the null hypothesis, the steps outlined in Experiment 2 were 
explored. Knowing each T wave is composed of frequencies ranging high to low, it is 
hypothesized that sub-dividing these frequencies into groups and analyzing the ranges 
separately would locate a section in the T wave spectrum enabling the ttest2’s function to 
reject the null hypothesis. The results of the ttest2 function are outlined in Table 6.  
Table 6: ttest results of segmented T wave spectrum. 
Again, as before, the null option has not been rejected and the variations of the 
susceptible and resistant spectral T wave RMS data overlaps too much to significantly 
see variations between resistant canine and susceptible canine groups. However, just as 
before, noticing the probabilities listed in Table 6, the p-values correlating to segment 3 of 
both the recovery epoch and the recovered epoch have dropped closer to the desired value 
of 0.05. This drop even closer to 0.05, shows promise that a continued segmentation of 
the averaged T wave spectrum may yield results to reject the null hypothesis of the ttest2 
function. 
3.2 Number of subjects needed to reject null hypothesis 
With the ttest2 showing a very strong trend toward a 5% probability, this leads to the 
question: How many resistant canines and susceptible canines are needed to reject the null 
hypothesis. Looking at the concept of Experiment 1, increasing the subject data pool, and  
segmented RMS values of the Susceptable T waves
Segment 1 
Occulsion 
Epoch
Segment 2 
Occulsion 
Epoch
Segment 3 
Occulsion 
Epoch
Segment 4 
Occulsion 
Epoch
Segment 1 
Recovery 
Epoch
Segment 2 
Recovery 
Epoch
Segment 3 
Recovery 
Epoch
Segment 4 
Recovery 
Epoch
Segment 1 
Recovered 
Epoch
Segment 2 
Recovered 
Epoch
Segment 3 
Recovered 
Epoch
Segment 4 
Recovered 
Epoch
H: 0 0 0 0 0 0 0 0 0 0 0 0
P: 0.7837 0.8328 0.823 0.7258 0.4455 0.7509 0.1495 0.5901 0.955 0.5125 0.1497 0.5986
C: -0.3394 -0.3455 -0.2319 -0.207 -0.1724 -0.4849 -0.601 -0.281 -0.3604 -0.2926 -0.5832 -0.1778
0.2628 0.2837 0.1889 0.1488 0.365 0.3598 0.1041 0.1676 0.342 0.5544 0.1003 0.2946
ttest 2 results of the segmented RMS valuse of the Resistant T waves compared to the
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using the equation below to determine the sample size needed to reject the null 
hypothesis of two normally distribute samples of equal size with different variance. [5] 
 
n = the appropriate sample size in each group to have a probability of 1-β (β=5%) of 
finding a significant difference  in the true differences in means between groups. 
Δ = Difference between the mean of the resistant canine RMS values and the susceptible 
canine RMS values. 
σ  = The standard deviations of two respective samples, in this case we estimate the 
standard deviations with the variances of the resistant canine RMS values and the 
susceptible canine RMS values. 
Z0 = 1.645 and Z1 =1.96. These values are given by the standard Gaussian distributions 
and are obtained by simply looking the values up. [5 ] 
Plugging in the appropriate values for the recovery epoch section of analysis, seen below, 
yields a value of n=60.3.  
 
Performing the same operation with the recovered epoch analysis yields a value of n = 
74.8. This equation shows that to reject the null hypothesis of the ttest2 function, 
approximately 120 total subjects, 60 animals in each group, will be needed for the 
sample size = n = ( 12 + 22)*(Zo +Z1)2 
                                        ------------------------------------------- 
              2 
Equation 1 
n = ((0.0246)
2 
+ (0.221)
2
)*(1.96 +1.645)
2 
         ----------------------------------------------------------------------- 
               
(0.148-0.0448)
2
 
Equation 2 
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recovery epoch analysis and, 150 total subjects, 75 animals in each group, will be needed 
for the recovered epoch analysis. 
 Another important equation that can be used to determine the number of animals 
needed to reject the null hypothesis, factors in the standard deviations of the data being 
analyzed. As seen in equation 3, the standard deviations for the susceptible case - 0.221 - 
is about 10 times larger than the standard deviation for the resistant case – 0.0246. Using 
another equation that determines the sample size needed for comparing the means of two 
normally distributed samples of unequal size, shown below, the number of EKG traces 
can be reduced. [5] 
 
All variables are the same as before except for k. K is the ratio of standard deviations. In 
this case K = 10. Applying values to the equation for the recovery epoch analysis shows 
that 8 resistant EKG traces and 35 susceptible EKG traces are needed to reject the null 
hypothesis. For the recovered epoch analysis 9 resistant EKG traces and 82 susceptible 
EKG traces are needed to reject the null hypothesis.   
 Equation 3 and 4 show that factoring the standard deviations ratio into account, 
when determining the number of animals needed to reject the null hypothesis, is beneficial 
Equation 3 
And 
Equation 4 
 
Sample size = n1 = ( 12 + 22/K)*(Zo +Z1)2 
                    ------------------------------------------------------- 
                                           2 
Sample size = n2 = (K* 12 + 22)*(Zo +Z1)2 
                    ------------------------------------------------------- 
                                           2 
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when analyzing the recovery epoch since 8 + 35 = 43 which is less than using the 
equation that assumes equal data sets - equation 2. Regarding the recovered epoch 
analysis, using an equal sample size would be less beneficial because it would require 150 
animals compared the 82 + 9 = 91 traces calculated using equation 3 and 4. 
 Applying the same equations and concepts mentioned before to Experiment 2,it 
would take a total of 37.5 animals, 19 resistant and 19 susceptible, to reject the 2 variable 
ttest null hypothesis of the recovery epoch in segmented zone 3. To reject the null 
hypothesis of the recovered epoch in segmented zone 3, it would take a total of  39.4 
animals, 20 resistant and 20 susceptible. The benefits of segmenting the spectral epochs, 
in addition to lower the p-values, is that it allows for a smaller subject pool required to 
reject the null hypothesis, thus showing statistical significance when finding variations 
between T wave spectrums of susceptible and resistant canine groups. 
3.3 Difficulties 
Some difficulties encountered with obtaining the number of traces needed to reject 
the null hypothesis, is that the data being analyzed, both CBF and the EKG, need to be in 
good condition.  During the data acquisition stages, some EKG where filled with too much 
noise and the CBF did not always mark an accurate occlusion section.  The EKG noise 
made it difficult to locate the T wave, while the inaccurate CBF occlusion section made it 
impossible to locate the epochs to be analyzed. For this reason it was difficult to locate 
data.   
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CHAPTER IV 
CONCLUSION 
In this chapter we discuss the conclusions that can be drawn from the data presented in 
the previous chapter. In addition, some discussion about possible extension of this study 
is included. 
4.1 Conclusion 
 Based on data presented and arguments made in the last chapter, that this method 
of analysis shows promise in distinguishing VF resistant vs. susceptible animals. 
Provided the p-value trends continue as segmentation of the averaged T wave spectra 
RMS, the null hypothesis of the ttest2 should reject if enough animals are used n the 
study. This rejection would verify variations between the T wave spectrum of canines 
resistant to ventricular fibrillation and those susceptible to ventricular fibrillation.  
 At the thesis inception, the method was to analyze the T wave spectrum of pre-
identified canines during the ischemia. This ischemia was represented by the occlusion of 
the left circumflex coronary artery. After statistically analyzing the averaged T wave 
spectrum root mean square, it was determined that analyzing the epochs of a recovery 
section after an occlusion to the left circumflex artery, and the recovered epoch after the 
occlusion would prove more statistically valuable.  
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 Additionally, segmenting the T wave spectrum into high, mid-high, mid-low, and 
low sections, showed promise toward statistical significance. Segmenting the T wave 
allows for a more accurate comparison of T wave variations between canine susceptible 
and resistant to ventricular fibrillation. These comparisons of T wave spectral variations 
show that by analyzing the T wave in the frequency domain, it can be shown a canine is 
susceptible or resistant to ventricular fibrillation 
4.2 Summary and extensions 
In this thesis, we have presented a method for determining the susceptibility or resistivity 
of a canine to ventricular fibrillation by analyzing the T wave spectrum of an EKG. While 
the process was not yet proven to have statistical significance, the theory is encouraging.
 Further work in this area might implement further spectral segmentation of the T 
wave. This would allow for a finer analysis of the T wave and the ability to more 
accurately isolate the T wave spectral range responsible for defining the spectral T wave 
variation indicative of canines resistive or susceptive to ventricular fibrillation. 
 While attempting the general solution, mentioned above, several details were set in 
order to complete the project in a timely fashion. However, if these can be generalized as 
well, the routine may have even broader applications. One example would be to analyze 
the P-wave spectrally to determine if atria arrhythmias can be pre-diagnosed. Another 
example would not ignore the phase shift of the t-wave with the assumption that data 
may be hidden in this spectrum too. However, it is clear that these are still drawbacks, 
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inefficiencies, and isolation shortcomings. Only future work can build upon this process 
in an attempt to more accurately determine ventricular susceptibility or resistivity to 
ventricular fibrillation in an in vivo canine model. 
4.3 Training Principles 
This thesis acted as an excellent educational tool.  Not only did it develop Matlab coding 
skills, but it also demonstrated a practical application to the theories taught through out 
my engineering career. This thesis allowed for a project that was a personal education 
tool, bridging engineering and medicine; two areas of extreme personal interest of 
engineering and medicine.  The opportunities to observe and assist in open heart surgery 
provided first hand exposure to the field of medicine, while the development and analysis 
of the collected data provided and engineering aspect. Additionally, practical statistics 
were utilized allowing me to see the significance of my data, oppose to simply trusting 
theory and a professors word that the math behind the theory works. Most importantly, 
the thesis allowed for an interdisciplinary project that not only involved knowledge of 
multiple fields, but required the development of communications skills.  Learning how to 
talk amongst engineers and then translate information into a physician language proved to 
be and will continue to be a valuable asset. 
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